These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 14261424)
1. PROGESTIN-ESTROGEN (SC 11,800) THERAPY AND THE HEMOSTATIC MECHANISM--A CONTROLLED STUDY. MILLER SP; LEE SL; RITZ N Metabolism; 1965 Mar; 14():SUPPL:398-410. PubMed ID: 14261424 [No Abstract] [Full Text] [Related]
2. [ETHYNODIOL DIACETATE (SC 11800) IN THE TREATMENT OF LUTEAL INSUFFICIENCY]. BERNARD I Ann Endocrinol (Paris); 1964; 25():179-82. PubMed ID: 14163475 [No Abstract] [Full Text] [Related]
3. [BLOOD COAGULATION PHENOMENA IN THE COURSE OF TREATMENT WITH COMBINED VINYLESTRENOLONE AND ETHINYLESTRADIOL]. MALAGOLI F; SIDERI L Gazz Med Ital; 1964 Apr; 123():116-8. PubMed ID: 14145737 [No Abstract] [Full Text] [Related]
4. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
5. REDUCTION OF SIDE EFFECTS FROM OVULATION SUPPRESSION BY THE USE OF NEWER PROGESTIN COMBINATIONS. ANDREWS WC; ANDREWS MC Fertil Steril; 1964; 15():75-83. PubMed ID: 14105096 [No Abstract] [Full Text] [Related]
9. OPTIMUM DOSAGE FOR ESTROGEN-PROGESTOGEN BALANCE TO INHIBIT OVULATION. JACKSON MC; LINN R Int J Fertil; 1964; 9():75-86. PubMed ID: 14106271 [No Abstract] [Full Text] [Related]
10. [HORMONE EXCRETIONS AND BLOOD COAGULATION FACTORS DURING ORAL GESTAGEN-ESTROGEN THERAPY (EVALUATION OF THE RISK OF THROMBOPHLEBITIS)]. HALLER J; KOENIG A; POLIWODA H Geburtshilfe Frauenheilkd; 1965 Mar; 25():215-31. PubMed ID: 14289766 [No Abstract] [Full Text] [Related]
11. NEW ORAL CONTRACEPTIVE: SEQUENTIAL ESTROGEN AND PROGESTIN. GOLDZIEHER JW; BECERRA C; GUAL C; LIVINGSTON NB; MAQUEO M; MOSES LE; TIETZE C Am J Obstet Gynecol; 1964 Oct; 90():404-11. PubMed ID: 14212801 [No Abstract] [Full Text] [Related]
12. ORAL CONTRACEPTIVE HORMONES AND BLOOD COAGULABILITY. THOMSON JM; POLLER L Br Med J; 1965 Jul; 2(5456):270-3. PubMed ID: 14310204 [No Abstract] [Full Text] [Related]
13. CIRCULATION, BLOOD COAGULATION, AND CLINICAL OBSERVATIONS DURING HORMONAL SUPPRESSION OF OVULATION. BREHM H Int J Fertil; 1964; 9():45-56. PubMed ID: 14106268 [No Abstract] [Full Text] [Related]
14. Ethynodiol diacetate as a new, highly potent oral inhibitor of ovulation. PINCUS G; GARCIA CR; PANIAGUA M; SHEPARD J Science; 1962 Oct; 138(3538):439-40. PubMed ID: 13943649 [TBL] [Abstract][Full Text] [Related]
15. EFFECT OF A PROGESTIN-ESTROGEN ORAL CONTRACEPTIVE ON BLOOD CLOTTING FACTORS. HOUGIE C; RUTHERFORD RN; BANKS AL; COBURN WA Metabolism; 1965 Mar; 14():SUPPL:411-7. PubMed ID: 14261425 [No Abstract] [Full Text] [Related]
16. [EXPERIENCES WITH A LOW-DOSED GESTAGEN-ESTROGEN MIXTURE FOR OVULATION INHIBITION]. KLOSS W Med Klin; 1965 Jun; 60():1029-35. PubMed ID: 14311925 [No Abstract] [Full Text] [Related]
17. ORAL CONTRACEPTION IN PRACTICE. JACKSON MC J Reprod Fertil; 1963 Aug; 6():153-73. PubMed ID: 14065347 [No Abstract] [Full Text] [Related]
18. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. Wilson ES; Cruickshank J; McMaster M; Weir RJ Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589 [TBL] [Abstract][Full Text] [Related]